An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
State University of New York at Buffalo
Buckinghamshire Healthcare NHS Trust
Johns Hopkins University
University of Michigan
Abide Therapeutics
Beth Israel Deaconess Medical Center
University of California, San Francisco